Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer
- PMID: 11025711
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer
Abstract
Purpose: The accurate prediction of pathological stage of prostate cancer using preoperative factors is a critical aspect of treatment. In 1997 Partin et al published tables predicting pathological stage using clinical stage, Gleason score and prostate specific antigen (PSA). We tested the validity of the Partin tables.
Materials and methods: From 1990 to 1996 inclusively 5,780 patients underwent bilateral pelvic lymphadenectomy and radical prostatectomy for prostate cancer at the Mayo Clinic. However, only 2,475 of these patients met all inclusion criteria of no preoperative treatment, known biopsy Gleason score, available preoperative PSA done either before biopsy or more than 28 days after biopsy and clinical stage T1, T2 or T3a. Among the 2,475 patients 15 had positive lymph nodes and planned prostatectomy was abandoned. The receiver operating characteristics (ROC) curve area, observed and predicted Partin rates of each pathological stage, and positive and negative predictive values were used to compare the Mayo study to the Partin tables.
Results: The distribution of pathological stage was organ confined in 67% of Mayo cases versus 48% in the Partin study, extracapsular without seminal vesicle or node involvement in 18% versus 40%, seminal vesicle involvement without nodes in 9% versus 7% and were positive nodes in 6% versus 5%. Using the predicted probabilities of Partin et al the ROC curve area for predicted node positive disease was 0.84 for Mayo cases compared to an estimated 0. 82 in the Partin series. The ROC curve area for predicting organ confined cancer was 0.76 for the Mayo Clinic compared to an estimated 0.73 for the Partin series. The observed rates of node positive disease were similar to those predicted (Partin) based on clinical stage, PSA and Gleason score. For organ confined disease Mayo rates were consistently higher than those predicted from the Partin series using a cut point of 0.50 or greater. Positive and negative predictive values were 0.83 and 0.49 versus 0.63 and 0.70 for the Mayo Clinic and Partin series.
Conclusions: Our study provides strong evidence that sensitivity and specificity of the Partin tables for external clinical sites are similar to what was reported.
Comment in
-
Predicting outcomes after radical prostatectomy.J Urol. 2000 Nov;164(5):1601. J Urol. 2000. PMID: 11025713 No abstract available.
Similar articles
-
Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.J Urol. 2008 Sep;180(3):904-9; discussion 909-10. doi: 10.1016/j.juro.2008.05.047. Epub 2008 Jul 17. J Urol. 2008. PMID: 18635221
-
Validation of 2001 Partin tables in Turkey: a multicenter study.Eur Urol. 2005 Feb;47(2):185-9. doi: 10.1016/j.eururo.2004.08.002. Eur Urol. 2005. PMID: 15661412
-
The newer the better? Comparison of the 1997 and 2001 partin tables for pathologic stage prediction of prostate cancer in China.Urology. 2008 Nov;72(5):1096-101. doi: 10.1016/j.urology.2008.07.047. Epub 2008 Sep 26. Urology. 2008. PMID: 18822453 Clinical Trial.
-
Prostate biopsy: who, how and when. An update.Can J Urol. 2005 Feb;12 Suppl 1:44-8; discussion 99-100. Can J Urol. 2005. PMID: 15780165 Review.
-
No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.Urology. 2004 Mar;63(3):528-31. doi: 10.1016/j.urology.2003.09.064. Urology. 2004. PMID: 15028451 Review.
Cited by
-
Multi-parametric MRI of the prostate: Factors predicting extracapsular extension at the time of radical prostatectomy.Asian J Urol. 2017 Jan;4(1):31-36. doi: 10.1016/j.ajur.2016.07.002. Epub 2016 Nov 19. Asian J Urol. 2017. PMID: 29264204 Free PMC article.
-
Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers.Future Oncol. 2016 Nov;12(21):2417-2430. doi: 10.2217/fon-2016-0178. Epub 2016 Jul 12. Future Oncol. 2016. PMID: 27400645 Free PMC article. Review.
-
Prostate cancer markers: An update.Biomed Rep. 2016 Mar;4(3):263-268. doi: 10.3892/br.2016.586. Epub 2016 Jan 29. Biomed Rep. 2016. PMID: 26998261 Free PMC article.
-
Predicting the risk of non-organ-confined prostate cancer when perineural invasion is found on biopsy.Urology. 2014 May;83(5):1117-21. doi: 10.1016/j.urology.2013.12.042. Epub 2014 Mar 19. Urology. 2014. PMID: 24655556 Free PMC article.
-
An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011.BJU Int. 2013 Jan;111(1):22-9. doi: 10.1111/j.1464-410X.2012.11324.x. Epub 2012 Jul 26. BJU Int. 2013. PMID: 22834909 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous